Tuncay Hazirolan

Tuncay Hazirolan

Auto-generated profile, based on publicly available information

Tuncay Hazirolan

Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2020 in Acta Cardiologica
Verified
Journal Article
Closed access
DKDuygu Kocyigit
Duygu Kocyigit
LTLale TOKGÖZOĞLU
Lale TOKGÖZOĞLU
KGKadri M. Gurses
Kadri M. Gurses
MHMarcus Henricsson
Marcus Henricsson
JBJan Borén
Jan Borén
NONecla Ozer
Necla Ozer
Histopathological changes in calcific aortic stenosis (CAS) resemble changes in coronary atherosclerosis. Concerning recent evidence on dietary and gut microbiota-related metabolites representing p...

17 June 2021 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
GYGozde Kubra Yardimci
Gozde Kubra Yardimci
SDSelin Ardali Duzgun
Selin Ardali Duzgun
EBErtugrul Cagri Bolek
Ertugrul Cagri Bolek
LKLevent Kilic
Levent Kilic
Ugur CanpolatUgur Canpolat
Ugur Canpolat
OKOmer Karadag
Omer Karadag

1 January 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
CCCem Coteli
Cem Coteli
THTuncay Hazirolan
Tuncay Hazirolan
KAKudret Aytemir
Kudret Aytemir
AEAHMET GÜRKAN ERDEMIR
AHMET GÜRKAN ERDEMIR
EBEmine Nilay Bakir
Emine Nilay Bakir
NONecla Ozer
Necla Ozer
Background/aim: The presence of atrial fibrosis has already been known as a risk factor for atrial fibrillation (AF) development. We aimed to evaluate atrial fibrosis with previously defined three different methods, which were cardiac magnetic resonance imaging (C-MRI), echocardiographic strain imaging, and biomarkers and show the relationship between these methods in patients with AF scheduled for cryoballoon ablation. Materials and methods: A total of 30 patients were enrolled. Atrial T1 relaxation durations were measured using C-MRI before the procedure of atrial fibrillation catheter ablation. Fibroblast growth factor-21 (FGF-21) and fibroblast growth factor-23 (FGF-23) levels were measured at serum derived from the femoral artery (Peripheral FGF 21 and 23) and left atrium blood samples (Central FGF 21 and 23) before catheter ablation. Preprocedural transthoracic echocardiography was performed. The median follow-up duration for atrial tachyarrhythmia (ATa) recurrence was 13 (12-18 months) months. Results: The mean ages of the study group were 55.23 +/- 12.37 years, and there were 17 (56.7%) female patients in study population. There were negative correlations between post contrast T1 relaxation durations of both posterior and posterosuperior atrium, and central FGF-23 (r: - 0.561; p = 0.003; r:-0.624; p = 0.001; Posterior T1 vs. central FGF-23 levels and Posterosuperior T1 vs central FGF-23 levels, respectively). The positive correlations were observed between postcontrast posterior T1 relaxation durations and left ventricle ejection fraction (r:0.671; p = 0.001); left atrial emptying fraction (r:0.482; p = 0.013); peak atrial longitudinal strain (r:0.605; p = 0.001), and peak atrial contraction strain (r:0.604; p = 0.001). Also negative correlation was observed between postcontrast posterior T1 relaxation durations, and left atrial volume index (r: - 0.467; p = 0.016). Conclusion: Our studies showed that there are correlations between T1 mapping of atrial tissue, biomarkers, and atrial mechanics evaluated with transthoracic echocardiography. Our findings are significant as they demonstrate the compatibility of these techniques for the atrial fibrosis evaluation.

19 February 2021 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
Ugur CanpolatUgur Canpolat
Ugur Canpolat
HYHikmet Yorgun
Hikmet Yorgun
THTuncay Hazirolan
Tuncay Hazirolan
KAKudret Aytemir
Kudret Aytemir
The common ostium of left and right inferior PVs is an extremely rare variant which was only reported in 16 cases undergoing catheter ablation. Thus, electrophysiologists should be careful about such an exremely rare PV variants for the safety and efficacy of ablation. Pre‐procedural CTA is a valuable tool to decide on the ablation strategy in patients with such a very rare PV anomaly.

1 March 2015 in Transplantation Proceedings
Verified
Journal Article
Closed access
HAH. Akoglu
H. Akoglu
YYYildirim Yildirim
Yildirim Yildirim
GEG. Eldem
G. Eldem
RYR. Yilmaz
R. Yilmaz
THT. Hazirolan
T. Hazirolan
YEY. Erdem
Y. Erdem

8 July 2021 in Acta Cardiologica
Verified
Journal Article
Closed access
SSSuleyman Nahit Sendur
Suleyman Nahit Sendur
THTuncay Hazirolan
Tuncay Hazirolan
BABusra Aydin
Busra Aydin
İLİNCİLAY LAY
İNCİLAY LAY
MAMehmet Alikasifoglu
Mehmet Alikasifoglu
TETomris Erbas
Tomris Erbas
We have investigated the role of a cardiomyokine, follistatin-like 1 (FSTL1), and its single nucleotide polymorphism on acromegalic cardiomyopathy. The study was performed as a cross-sectional case research in a Tertiary Referral Centre. Forty-six patients with acromegaly (29 F–17 M, mean age: 50.3 ± 12.1 years) were included. FSTL1 levels were measured and the rs1259293 region of the FSTL1 gene was subjected to polymorphism analysis. 1.5 Tesla MRI was used to obtain cardiac images. There were 15 active (6 F–9M) and 31 (22 F–9M) controlled patients. Active patients had a higher left ventricular mass (LVM) and left ventricular mass index (LVMi). GH levels were positively correlated with left ventricular end-diastolic volume index (LVEDVi), stroke volume index (SVi), cardiac index (Ci), LVM and LVMi; r = 0.35, 0.38, 0.34, 0.39 and 0.39, respectively. IGF-1 index was positively correlated with LVEDVi, left ventricular end-systolic volume index (LVESVi), SVi, Ci, LVM and LVMi; r = 0.36, 0.34, 0.32, 0.31, 0.42 and 0.42, respectively. Twenty out of 46 patients with acromegaly (43.5%) had myocardial fibrosis. FSTL1 levels were neither correlated with disease activity nor with any functional and structural cardiac parameter. Multivariate linear regression analysis revealed no association between FSTL1 and any study parameters. The rs1259293 variant genotype CC was significantly associated with low left ventricular mass. Serum FSTL1 levels are not associated with functional and structural measures of myocardium in patients with acromegaly. However, the risk of left ventricular hypertrophy is reduced in CC genotyped individuals of FSTL1.